Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department

Clinical trial NCT07246187 · RECRUITING

Trial details

NCT number: NCT07246187
Sponsor: Mercy Bon Secours Saint Vincent Medical Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cannabinoid Hyperemesis Syndrome

Start date: 2025-11-06
Primary completion: 2026-10-31
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.